Category Archives: Bisphosphonates

Featured Stories

New York Man Claims Biomet Metal-on-Metal Hip Implant Caused Pain, Disability

A New York man claims his metal-on-metal hip implant was defective and required replacement within a year of receiving it. This has left him facing a lifetime of pain, disability, and rising medical costs.

Read More

Birth Control Shot Depo-Provera may Increase HIV Risk

Birth Control Shot Depo-Provera may Increase HIV Risk, Study Suggests

A new study has linked the use of Depo-Provera (medroxyprogesterone acetate), an injectable type of birth control, to an increased risk of HIV infection.

Read More

Bleeding Side Effects of Pradaxa, Xarelto Have Some Doctors Concerned

Some heart doctors are raising concerns about a new class of heart drugs that include Pradaxa. Recently, a number of doctors interviewed by Reuters said they were hesitant to prescribe Pradaxa, as well as another blood thinner called Xarelto, because of concerns regarding the risk of stroke, serious bleeding ...

Read More

System for Tracking Prescription Drug Side Effects Flawed

Study Finds System for Tracking Prescription Drug Side Effects Flawed

System for keeping track of dangerous side effects of prescription drugs is flawed because drug makers are submitting incomplete information about problems to the FDA.

Read More

Actos Side Effects Lawyers Says Whistleblower Revelations Could Boost Bladder Cancer, Heart Failure Lawsuits

An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.

Read More

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

E. District of Missouri denied motion to dismiss conspiracy claims. Lawsuit alleges the defendants conspired to misrepresent true dangers with use of talcum powder.

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed. According to press release issued Jan. 7, a resolution was introduced by Council Member Margaret Chin, Council Speaker Melissa Mark-Viverito and Council Members Paul Vallone and I. ...

Read More

Metal-on-Metal Hip Implant Lawyer Takes Issue with Statements Made by DePuy Orthpaedics Official During FDA Meeting

An attorney with a national law firm that represents victims of alleged metal-on-metal hip implant injuries has expressed dismay at some statements made last week regarding the regulation of all-metal hip replacement devices by an official with DePuy Orthopaedics. According to Daniel Burke, Senior Litigation Counsel at Parker ...

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Bisphosphonates Associated with Increased Risk of Atypical Hip Fractures, Researcher Says

The use of bisphosphonates, drugs prescribed to prevent hip fractures in women with osteoporosis, is associated with an increased risk of atypical fractures in this joint. The research is contained in a PhD thesis by Javier Gorricho-Mendívil, at the NUP/UPNA-Public … Continue reading

Posted in Bisphosphonates, Fosamax, Health Concerns, Pharmaceuticals |

Study: Bisphosphonates Use Raises Risks for Atrial Fibrillation

bisphosphonate_atrial_fibrilation

New research has found that bisphosphonate use was tied to a significant increased risk of both atrial fibrillation (AF) and serious AF. Bisphosphonates include Fosamax (alendronate sodium), Reclast and Zometa (zoledronic acid), Boniva (ibandronate sodium), Didronel (etidronate disodium), Actonel (risedronate … Continue reading

Posted in Bisphosphonates, Pharmaceuticals |

Woman Alleges Bisphosphonates Led to “Dead Jaw”

actonel_dead_jaw

We’ve long been following risks associated with bisphosphonate (BP) drugs like Fosamax, Boniva, and Actonel, which are approved to treat bone-weakening diseases like osteoporosis and Paget’s disease. Cancer patients also often undergo therapy with Aredia, Zometa, and other bisphosphonate drugs … Continue reading

Posted in Bisphosphonates, Pharmaceuticals |

Bisphosphonates Increase Bone Disease Risks Following Tooth Extraction

We’ve been following risks associated with bisphosphonate (BP) drugs. As we’ve explained, some bisphosphonates, like Fosamax, Boniva, and Actonel, are approved to treat bone-weakening diseases like osteoporosis and Paget’s disease. Cancer patients often undergo therapy with Aredia, Zometa, and other … Continue reading

Posted in Bisphosphonates, Pharmaceuticals |

Woman who suffered jawbone loss due to Fosamax reaches damages settlement with Merck

A woman who claims her taking Fosamax in the prevention of bone loss caused by osteoporosis resulted in her developing decay of her jaw bone has reached a confidential settlement with the makers of the drug. Merck & Co. has … Continue reading

Posted in Bisphosphonates, Fosamax, Legal News, Pharmaceuticals | Tagged , |

Bisphosphonate drugs Fosamax, Boniva not right for women in “pre-menopause”

Women suffering from osteopenia, often referred to as pre-menopause, should avoid taking bisphosphonate drugs like Fosamax to prevent bone loss in most circumstances. Consumer Reports magazine’s team of medical experts issued this advisory when questioned about the use of these … Continue reading

Posted in Bisphosphonates, Fosamax, Pharmaceuticals | Tagged , |

Study Finds Dental Work Triggers Bisphosphonate-Induced ONJ in Blood Cancer Patients

Dental extractions appear to be a major trigger for Ostenecrosis of the Jaw (ONJ) in people receiving bisphosphonates to treat multiple myeloma or Waldenstrom’s macroglobulinemia, says a new study out of Italy.  According to the authors of the report, which … Continue reading

Posted in Bisphosphonates, Pharmaceuticals | Tagged |

Rhode Island Woman’s Lawsuit Claims Fosamax Caused Painful Femur Fracture

Yet another woman who used Fosamax has filed a lawsuit claiming the bisphosphonate drug caused her to suffer a painful femur fracture.  This new lawsuit was filed on June 22nd in the Superior Court of New Jersey, Atlantic County Law … Continue reading

Posted in Bisphosphonates, Pharmaceuticals | Tagged |

Lawsuit Alleges Woman Suffered Femur Fracture Due to Fosamax

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of a woman who took Fosamax (alendronate) and subsequently suffered a femur fracture; the lawsuit alleges that Merck’s osteoporosis drug caused the fracture. The Fosamax lawsuit was filed … Continue reading

Posted in Bisphosphonates, Pharmaceuticals | Tagged |

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that … Continue reading

Posted in Bisphosphonates, Fosamax, Pharmaceuticals | Tagged |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.